SpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform.

Three testimonies were delivered in court in the prosecution of Kwabena Adu-Boahene, the former Director-General of the National Signals Bureau (NSB) and his wife.

Get Honey for FREE today ▸ <a href=" Honey finds coupons with one click. Thanks to Honey for sponsoring! Keyboard build ...

Wu draws more small donations from city residents while Kraft attracts larger contributions and significant out-of-state ...

BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...

SpyGlass Pharma secures $75 million in Series D funding to enhance its innovative drug delivery platform for long-term ...

On the occasion of World Multiple Sclerosis Day, Ad Scientiam announced that MSCopilot ®, its class IIa Software as a Medical Device (SaMD) dedicated to the monitoring of people living with multiple ...

Q1 2026 Earnings Call Transcript May 29, 2025 UiPath Inc. beats earnings expectations. Reported EPS is $0.11, expectations ...

Elastic's valuation remains attractive as growth accelerates, driven by rising adoption of Generative AI. Learn why ESTC ...

Stakeholders agree that the regulatory overhaul sends a strong signal to both local and international investors, positioning ...

Discover innovative ways businesses are leveraging Google Cloud and Gemini AI for scalability, automation, and smarter data ...